focus -WSS

focus

author：comprehensive 2025-09-30 17:43:42 - browse：57846

Microsoft's head of research Peter Lee speaking at STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could also lead clinicians, and patients to experiment with it before there is wider consensus on how to navigate its biases and other pitfalls, Microsoft’s head of research Peter Lee said Thursday at STAT’s Breakthrough Summit.

About a month after OpenAI — Microsoft has a significant financial stake in the company — launched its chatbot in 2022 on November 30, which happened to be Lee’s birthday, he got a note from a doctor friend who said he’d used it so his receptionist could file after-visit summaries for patients. While Lee and a handful of other doctors at Microsoft had been impressed with the GPT-4’s capabilities, they knew it had weaknesses.

“The emotions were really mixed. I mean we were thrilled,” he said, but then “just within minutes there’s a feeling of dread. We had already come to the realization that GPT-4 would be prone to issues, issues of bias, hallucination, mathematical and logical errors,” he said. “And so, there’s an immediate question: ‘Should we allow this to happen?’”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Intellia plays down concerns on accidental germline transmission

explore

focus

hotspot

WSS

Lupron, used to halt puberty in children, may cause lasting health problems

Wegovy improves function in certain heart failure patients

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

As obesity drug market grows, telehealth companies court payers

STAT wants to know your pick for a great summer read or listen

Republicans love RFK Jr. What's that tell us about health in 2024?

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

The cancer drug shortage isn’t new — and neither are the solutions

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Moonlake's readout produced a cash windfall. Risks remain

Crowdfunding for unproven stem cell procedures spreads misinformation

Tori Bowie and the unacceptable rates of Black maternal death

Vivek Ramaswamy made waves in the debate, much as in biotech

Wildfire smoke exposes gaps in outdoor worker protections

Skip the lead apron during X

Trump demands the U.S. pay no more for drugs than other countries … again

UpToDate has a racism problem: Dr. Stanley Goldfarb

explore

STAT wants to know your pick for a great summer read or listen

Meadows told special counsel he could not recall Trump ever declassifying Mar

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

PBMs are inflating the cost of generic drugs. They must be reined in

Being 'nonadherent' patient made me a more empathetic doctor

Republicans love RFK Jr. What's that tell us about health in 2024?

explore

focus

hotspot

Wikipedia